"/> Invitrogen™ Peptide synthétique IRF7 humain | B-LABO France

Invitrogen™ Peptide synthétique IRF7 humain

Réf. : BL-RE-176292Réf. fabricant : 15226629 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
3665
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q92985
Nom usuel
Human IRF7
Marque
Invitrogen

IRF7 Synthetic Peptide, PEP-0414, from Invitrogen.

Interferons (IFNs) are involved in a multitude of immune interactions during viral infections and play a major role in both the induction and regulation of innate and adaptive antiviral mechanisms. During infection, host-virus interactions signal downstream molecules such as transcription factors such as IFN regulatory factor-3 (IRF3) which can act to stimulate transcription of IFN-a/b genes. IRF7 has been shown to play a role in the transcriptional activation of virus-inducible cellular genes, including interferon beta chain genes. IRF7 play a major role in the innate immune pathway, interacting with the Toll-like receptor (TLR) adaptor proteins MyD88 and Tirp/TRAM and functioning as an intermediate TLR4 and TLR9 signaling. There are at least four differentially spliced isoforms of IRF7, although their function has not been clearly established.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-176292
Réf. fabricant15226629
Gene ID (Entrez)3665
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ92985
Nom usuelHuman IRF7
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)IRF7
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.